Cargando…
1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies
| Autores principales: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454311/ http://dx.doi.org/10.1016/j.annonc.2021.08.1583 |
| _version_ | 1784570459373699072 |
|---|---|
| author | Zakurdaeva, K. Gavrilina, O.A. Vasileva, A.N. Dubov, S.K. Dubov, V.S. Vorobyev, V.I. Butaev, L.S. Gavrilova, L.V. Toropova, I.Y. Popova, M. Siniaev, A. Kaplanov, K. Petrenko, A.A. Ochirova, O.I. Chelysheva, E.Y. Sveshnikova, Y.V. Shuvaev, V. Grishunina, M.E. Chabaeva, Y.A. Savchenko, V.G. |
| author_facet | Zakurdaeva, K. Gavrilina, O.A. Vasileva, A.N. Dubov, S.K. Dubov, V.S. Vorobyev, V.I. Butaev, L.S. Gavrilova, L.V. Toropova, I.Y. Popova, M. Siniaev, A. Kaplanov, K. Petrenko, A.A. Ochirova, O.I. Chelysheva, E.Y. Sveshnikova, Y.V. Shuvaev, V. Grishunina, M.E. Chabaeva, Y.A. Savchenko, V.G. |
| author_sort | Zakurdaeva, K. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8454311 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84543112021-09-21 1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies Zakurdaeva, K. Gavrilina, O.A. Vasileva, A.N. Dubov, S.K. Dubov, V.S. Vorobyev, V.I. Butaev, L.S. Gavrilova, L.V. Toropova, I.Y. Popova, M. Siniaev, A. Kaplanov, K. Petrenko, A.A. Ochirova, O.I. Chelysheva, E.Y. Sveshnikova, Y.V. Shuvaev, V. Grishunina, M.E. Chabaeva, Y.A. Savchenko, V.G. Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2021-09 2021-09-21 /pmc/articles/PMC8454311/ http://dx.doi.org/10.1016/j.annonc.2021.08.1583 Text en Copyright © 2021 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Zakurdaeva, K. Gavrilina, O.A. Vasileva, A.N. Dubov, S.K. Dubov, V.S. Vorobyev, V.I. Butaev, L.S. Gavrilova, L.V. Toropova, I.Y. Popova, M. Siniaev, A. Kaplanov, K. Petrenko, A.A. Ochirova, O.I. Chelysheva, E.Y. Sveshnikova, Y.V. Shuvaev, V. Grishunina, M.E. Chabaeva, Y.A. Savchenko, V.G. 1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies |
| title | 1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies |
| title_full | 1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies |
| title_fullStr | 1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies |
| title_full_unstemmed | 1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies |
| title_short | 1590P Treatment outcomes and antibody immunity to SARS-CoV-2 in patients with hematological malignancies |
| title_sort | 1590p treatment outcomes and antibody immunity to sars-cov-2 in patients with hematological malignancies |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454311/ http://dx.doi.org/10.1016/j.annonc.2021.08.1583 |
| work_keys_str_mv | AT zakurdaevak 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT gavrilinaoa 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT vasilevaan 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT dubovsk 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT dubovvs 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT vorobyevvi 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT butaevls 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT gavrilovalv 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT toropovaiy 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT popovam 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT siniaeva 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT kaplanovk 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT petrenkoaa 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT ochirovaoi 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT chelyshevaey 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT sveshnikovayv 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT shuvaevv 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT grishuniname 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT chabaevaya 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies AT savchenkovg 1590ptreatmentoutcomesandantibodyimmunitytosarscov2inpatientswithhematologicalmalignancies |